Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Rating of "Moderate Buy" from Brokerages

Addus HomeCare logo with Medical background

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $131.63.

A number of research analysts have weighed in on the stock. Macquarie reiterated an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Stephens increased their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Royal Bank of Canada restated an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, StockNews.com lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Tuesday.

View Our Latest Report on Addus HomeCare

Addus HomeCare Stock Up 0.4 %

Shares of ADUS traded up $0.47 during mid-day trading on Friday, reaching $120.74. The company had a trading volume of 131,458 shares, compared to its average volume of 112,584. The stock has a 50 day moving average of $126.26 and a two-hundred day moving average of $124.06. The stock has a market capitalization of $2.19 billion, a P/E ratio of 27.63, a PEG ratio of 2.16 and a beta of 1.01. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. During the same quarter last year, the company earned $1.03 EPS. The business's revenue was up 7.1% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Esteban Lopez sold 500 shares of the company's stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company's stock, valued at $429,165. This trade represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ADUS. Point72 Asset Management L.P. lifted its holdings in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Addus HomeCare by 412.7% in the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company's stock valued at $36,739,000 after purchasing an additional 254,705 shares during the last quarter. Wasatch Advisors LP lifted its stake in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after purchasing an additional 110,010 shares during the last quarter. Ghisallo Capital Management LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter worth $11,611,000. Finally, Principal Financial Group Inc. increased its position in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after purchasing an additional 75,409 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should you invest $1,000 in Addus HomeCare right now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines